Press Releases

Webcast ImageWebcast
Q4 2012 Abiomed, Inc. Earnings Conference Call (Replay)
05/16/12 at 8:00 a.m. ET
Q4 2012 Abiomed, Inc. Earnings Conference Call
Wednesday, May 16, 2012 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
DateTitle 
05/16/12Abiomed Announces Record Fourth Quarter Revenue of $37.3 Million, Up 31% and Achieves Profitability for Full Fiscal Year
DANVERS, Mass., May 16, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD - News), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2012 revenue of $37.3 million, up 31% compared to revenue of $28.5 million in the same period of fiscal 2011, and GAAP net income of $2.6 million or $0.06 per diluted share compared to GAAP net loss of $1.8 million or a loss of $0.05 per basic and diluted share in the prior year. For the full fiscal year, total re... 
Printer Friendly Version
05/10/12Abiomed to Present at Bank of America Merrill Lynch 2012 Health Care Conference
DANVERS, Mass., May 10, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susie Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May 17, 2012 at 10:40 a.m. PDT. The conference will be held at the Encore at the Wynn Hotel, Las Vegas. ABOUT ABIOMED Based in Danvers, Massachusetts, Abiomed, Inc.... 
Printer Friendly Version
05/08/12Abiomed Announces Participation in Three Upcoming Physician Society Meetings: SCAI, HRS, & EuroPCR
DANVERS, Mass., May 8, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of break-through heart support technologies, today announced its participation in three upcoming physician society meetings: Society for Cardiovascular Angiography and Interventions (SCAI), May 9-12 in Las Vegas, Nevada – Booth 417 Heart Rhythm Society (HRS), May 9-12 in Boston, Massachusetts – Booth 1413 EuroPCR, May 15-18 in Paris, France – Booth M69 (Level 2) At all three mee... 
Printer Friendly Version
05/08/12Abiomed Fourth Quarter and Full Fiscal Year 2012 Earnings and Conference Call Notification
DANVERS, Mass., May 8, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Wednesday, May 16, 2012, the Company will release financial results for the fourth quarter and full year of fiscal 2012. The Company will host a conference call to discuss its results on Wednesday, May 16, 2012, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer; Robert L. Bowen, Vice President and Chief Financial Officer; and Susan Vissers Lisa, Senior Director, ... 
Printer Friendly Version
05/01/12Abiomed to Present at Deutsche Bank 37Th Annual Healthcare Conference
DANVERS, Mass., May 01, 2012 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Deutsche Bank 37th Annual Healthcare Conference on Tuesday, May 8, 2012 at 11:20 a.m. ET. The conference will be held at the InterContinental Hotel in Boston. ABOUT ABIOMED Based in Danvers, Massa... 
Printer Friendly Version
04/12/12Abiomed Receives CE Mark for Impella cVAD
- New Impella cVADTM Provides High Level of Percutaneous Hemodynamic Support DANVERS, Mass., Apr 12, 2012 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of break-through heart support technologies, today announced it has received CE Marking approval in the European Union to market the Impella cVAD device, a new percutaneous Impella(R) heart pump that provides peak flow of approximately 4 liters of blood per minute. ... 
Printer Friendly Version
04/03/12Abiomed Announces First Patient Supported with Impella cVAD
DANVERS, Mass.--(BUSINESS WIRE)--Apr. 3, 2012-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of break-through heart support technologies, today announced the successful first human use of the Impella cVADTM device, a new, percutaneous Impella heart pump that provides peak flow of approximately 4 liters of blood per minute. The Impella cVAD is designed to provide temporary circulatory support and reduce the workload of the heart muscle via ... 
Printer Friendly Version
03/21/12Abiomed Appoints Susan Vissers Lisa as Senior Director of Investor Relations and Corporate Development
DANVERS, Mass.--(BUSINESS WIRE)--Mar. 21, 2012-- Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the appointment of Susan Vissers Lisa, CFA, as Senior Director of Investor Relations and Corporate Development. Ms. Lisa brings more than 20 years of capital markets and healthcare experience, as well as an extensive background in medical technology, financial analysis, and sales and marke... 
Printer Friendly Version
03/02/12Abiomed to Present at the Cowen 32nd Annual Healthcare Conference
DANVERS, Mass.--(BUSINESS WIRE)--Mar. 2, 2012-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Robert L. Bowen, Vice President and Chief Financial Officer of Abiomed, will present at the Cowen 32nd Annual Healthcare Conference on Monday, March 5, 2012 at 1:30 p.m. ET. The conference will be held at the Boston Marriott Copley Place. ABOUT ABIOMED Ba... 
Printer Friendly Version
02/22/12Abiomed to Present at Citi 2012 Global Healthcare Conference
DANVERS, Mass.--(BUSINESS WIRE)--Feb. 22, 2012-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Citi 2012 Global Healthcare Conference on Tuesday, February 28, 2012 at 9:30 a.m. ET. The conference will be held at the Waldorf Astoria Hotel in New York City. ABOUT ABIOMED ... 
Printer Friendly Version
02/03/12Abiomed Reports Record Revenue of $32.2 Million and Earnings of $2.9 Million for Third Quarter of Fiscal 2012
-- Worldwide Impella Revenue Totals $27.7 Million, Up 31% With Double Digit Sequential and Year over Year Growth in Impella Utilization DANVERS, Mass.--(BUSINESS WIRE)--Feb. 3, 2012-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2012 revenue of $32.2 million, up 18% compared to revenue of $27.2 million in the same period of fiscal 2011 and GAAP net inco... 
Printer Friendly Version
01/31/12New Clinical Data for Symphony Presented in Late Breaking Clinical Trials Session at the Society of Thoracic Surgeons 2012 Annual Meeting
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jan. 31, 2012-- Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that the initial clinical data from the safety study for Symphony™ was presented by Renzo Cecere, M.D., FRCSC, FACS, Associate Professor of Surgery at McGill University, during the late-breaking clinical trials session at the Society of Thoracic Surgeons (STS) 2012 Annual Meeting in... 
Printer Friendly Version
01/26/12Abiomed Third Quarter Fiscal 2012 Earnings and Conference Call Notification
DANVERS, Mass.--(BUSINESS WIRE)--Jan. 26, 2012-- Abiomed, Inc. (NASDAQ: ABMD) announced today that on Friday, February 3, the Company will release financial results for the third quarter of fiscal 2012. The Company will host a conference call to discuss the results on Friday, February 3, 2012, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L. Bowen, Vice President and Chief Financial Officer, wi... 
Printer Friendly Version
12/12/11Abiomed 2011 Investor Day Webcast Replay Available
DANVERS, Mass.--(BUSINESS WIRE)--Dec. 12, 2011-- The webcast from the 2011 investor and analyst day for Abiomed, Inc. (NASDAQ: ABMD) is available for replay. To view the 2011 investor and analyst day presentation, please tune into the archive webcast via direct link at: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=95629&eventID=4233864. The archive webcast and conference call replay will be available until 11:59 p.m... 
Printer Friendly Version
12/07/11Abiomed to Release New Data and Product Updates at Investor & Analyst Day on December 9
DANVERS, Mass.--(BUSINESS WIRE)--Dec. 7, 2011-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, will release new data and product updates at its investor and analyst day on Friday, December 9, 2011, from 2:00 to 4:30 p.m. at the New York Palace in New York City. All interested attendees are encouraged to view the TCTMD webcast on www.abiomed.com prior to the event, as much of the material discussed... 
Printer Friendly Version
11/21/11Abiomed to Present at Piper Jaffray 23rd Annual Healthcare Conference
DANVERS, Mass.--(BUSINESS WIRE)--Nov. 21, 2011-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Piper Jaffray 23rd Annual Healthcare Conference on Wednesday, November 30, 2011 at 1:00 p.m. ET. The conference will be held at the New York Palace Hotel in New York City. ABOUT AB... 
Printer Friendly Version
11/14/11Abiomed Announces Symphony, an Implantable Synchronized Heart Pump Designed for Chronic Heart Failure Patients, at AHA 2011
DANVERS, Mass.--(BUSINESS WIRE)--Nov. 14, 2011-- Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced Symphony™, a new synchronized minimally invasive implantable cardiac assist device, designed to treat chronic patients with moderate heart failure by improving patient hemodynamics, and potentially improving quality of life. The device is designed with the primary goal of stabilizing the ... 
Printer Friendly Version
11/10/11Abiomed to Present at Lazard Capital Markets 8th Annual Healthcare Conference
DANVERS, Mass., Nov 10, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Lazard Capital Markets 8th Annual Healthcare Conference on Wednesday, November 16, 2011 at 9:30 a.m. ET. The conference will be held at the Pierre Hotel in New York. ABOUT ABIOMED Based in Danvers... 
Printer Friendly Version
11/07/11ACCF/AHA/SCAI 2011 Guidelines for Percutaneous Coronary Intervention Incorporates Impella Support
DANVERS, Mass. & SAN FRANCISCO, Nov 07, 2011 (BUSINESS WIRE) --Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the inclusion of hemodynamic support with Impella in the 2011 American College of Cardiology Foundation (ACCF)/American Heart Association (AHA)/ Society for Coronary Angiography Interventions (SCAI) for percutaneous coronary intervention (PCI). Released today by the Journal of... 
Printer Friendly Version
11/03/11Abiomed Reports Record Revenue of $29.5 Million and Profitability for Second Quarter of Fiscal 2012, Driven by 40% Impella Growth
-- GAAP Net Income of $0.6 Million DANVERS, Mass., Nov 03, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2012 revenue of $29.5 million, up 26% compared to revenue of $23.4 million in the same period of fiscal 2011. Financial and operating highlights during the second quarter of fiscal 2012 include: Fiscal second quarter ... 
Printer Friendly Version
11/01/11Abiomed Announces Investor & Analyst Day in New York City on December 9
Agenda to Include Presentations on Recent PROTECT II Data and New Product Updates DANVERS, Mass., Nov 01, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, will host an investor and analyst day on Friday, December 9, 2011 from 2:00 to 4:30 p.m. at the New York Palace in New York City. The agenda will include physician presentations, which will discuss the new data from PROTECT II and... 
Printer Friendly Version
10/27/11Abiomed Second Quarter Fiscal 2012 Earnings and Conference Call Notification
DANVERS, Mass., Oct 27, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD) announced today that on Thursday, November 3, the Company will release financial results for the second quarter of fiscal 2012. The Company will host a conference call to discuss the results on Thursday, November 3, 2011, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L. Bowen, Vice President and Chief Financial Officer, will... 
Printer Friendly Version
10/26/11Abiomed to Release New Protect II Data and Economic Study Results at TCT 2011; Over 20 Impella Presentations Included in Show Schedule
- Abiomed Sponsoring Three-Part Breakfast Series DANVERS, Mass., Oct 26, 2011 (BUSINESS WIRE) --Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced its schedule of events at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from November 7-11, at the Moscone Center in San Francisco. See below for the full schedul... 
Printer Friendly Version
09/19/11Abiomed Announces First Patient Enrolled In MINI-AMI Study
CRISP-AMI Trial Demonstrates Large Infarcts in Stable STEMI Patient Population DANVERS, Mass., Sep 19, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the first patient enrolled in MINI-AMI, an FDA prospective, randomized, controlled multi-center study to assess the role of 24-hours of direct unloading of the left ventricle with Impella(R) 2.5 support to reduce infarct s... 
Printer Friendly Version
09/16/11Abiomed to Present at Lazard Capital Markets Circulatory Assist Device Day
DANVERS, Mass., Sep 16, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Lazard Capital Markets 3rd Annual Circulatory Assist Device Day on Thursday, September 22, 2011 at 10:55 a.m. ET. The conference will be held at the Langham Hotel in Boston, MA. ABOUT ABIOMED Base... 
Printer Friendly Version
09/06/11Abiomed to Present at Morgan Stanley 2011 Global Healthcare Unplugged Conference
DANVERS, Mass., Sep 06, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Morgan Stanley 2011 Global Healthcare Conference on Wednesday, September 14, 2011 at 9:45 a.m. ET. The conference will be held at the Grand Hyatt Hotel in New York, NY. ABOUT ABIOMED Based in Danv... 
Printer Friendly Version
09/01/11Abiomed to Present at the Baird 2011 Healthcare Conference
DANVERS, Mass., Sep 01, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, Abiomed, will present at the Baird 2011 Healthcare Conference on Wednesday, September 7, 2011 at 9:30 a.m. ET. The conference will be held at the New York Palace in New York, NY. ABOUT ABIOMED Based in Danvers, Massa... 
Printer Friendly Version
08/11/11Abiomed To Present At The Wedbush 2011 Life Sciences: Management Access Conference
DANVERS, Mass., August 11, 2011 -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Robert Bowen, Chief Financial Officer and Vice President, will present at the Wedbush 2011 Life Sciences: Management Access Conference on Tuesday, August 16, 2011 at 11:10 a.m. ET. The conference will be held at Le Parker Meridien Hotel in New York, NY. ABOUT ABIOMED Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medica... 
Printer Friendly Version
08/04/11Abiomed Reports Revenue of $27.4 Million, up 25% over Prior Year, for First Quarter of Fiscal 2012
-- Impella Revenues Grow 33% to $22.2 Million DANVERS, Mass., Aug 04, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2012 revenue of $27.4 million, up 25% compared to revenue of $22.0 million in the same period of fiscal 2011. Financial and operating highlights during the first quarter of fiscal 2012 include: Fiscal first ... 
Printer Friendly Version
07/28/11Abiomed First Quarter Fiscal 2012 Earnings and Conference Call Notification
DANVERS, Mass., Jul 28, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD) announced today that on Thursday, August 4, the Company will release financial results for the first quarter of fiscal 2012. The Company will host a conference call to discuss the results on Thursday, August 4, 2011, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L. Bowen, Vice President and Chief Financial Officer, will... 
Printer Friendly Version
06/02/11Abiomed to Present at Jefferies 2011 Global Healthcare Conference
DANVERS, Mass., Jun 02, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Jefferies 2011 Global Healthcare Conference on Wednesday, June 8, 2011 at 4:30 p.m. ET. The conference will be held at the Mandarin Oriental in New York City. ABOUT ABIOMED Based in Danvers, Massachusetts... 
Printer Friendly Version
06/01/11Abiomed Announces Appointment of Paul G. Thomas to Board of Directors
DANVERS, Mass., Jun 01, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the appointment of Paul G. Thomas to the Company's Board of Directors. Currently, Mr. Thomas is Chief Executive Officer and Founder of Roka Bioscience, a company focused on the development and commercialization of molecular assays and is a Director of Orthovita, Inc. (NASDAQ: VITA). Mr. Tho... 
Printer Friendly Version
05/18/11Abiomed Reports Record Fiscal Fourth Quarter Revenue of $28.5 Million, up 24% over Prior Year
- $101.2 Million in Total Revenue With Gross Margins of 78% for Full Fiscal Year DANVERS, Mass., May 18, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2011 revenue of $28.5 million, up 24% compared to revenue of $23.0 million in the same period of fiscal 2010. Total revenue for the full fiscal year was $101.2 million, up 18% compared to rev... 
Printer Friendly Version
05/11/11Abiomed Announces PROTECT II Study Data Will Be Presented at EuroPCR 2011 in Late-Breaking Clinical Trial Session
- PROTECT II Presentation, Including Latest Data on 90-Day Results, Scheduled for Friday, May 20, Between 9:10 a.m. - 12:10 p.m. (CEST) DANVERS, Mass., May 11, 2011 (BUSINESS WIRE) --Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that data from the PROTECT II study will be presented by Jeffrey W. Moses, M.D., Director of Interventional Services at NewYork-Presbyterian Hospital/Columbia ... 
Printer Friendly Version
05/10/11Abiomed Fourth Quarter and Full Year Fiscal 2011 Earnings and Conference Call Notification
DANVERS, Mass., May 10, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD) announced today that on Wednesday, May 18, 2011, the Company will release financial results for the fourth quarter and full year of fiscal 2011. The Company will host a conference call to discuss the results on Wednesday, May 18, 2011, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L. Bowen, Vice President and Chief Financial... 
Printer Friendly Version
05/09/11Abiomed to Present at Bank of America Merrill Lynch 2011 Healthcare Conference
DANVERS, Mass., May 09, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2011 Healthcare Conference on Thursday, May 12, 2011 at 11:10 a.m. PT/ 2:10 p.m. ET. The conference will be held at the Encore at Wynn Las Vegas in Las Vegas, NV. ABOUT ABIOME... 
Printer Friendly Version
04/18/11New Data from the Protect II Study to Be Presented in Late Breaking Clinical Trials Session at Society for Cardiovascular Angiography Interventions 2011 Scientific Sessions
- PROTECT II Presentation, Including New Data and 90 Day Results, Scheduled for Friday, May 6 at 12 p.m. ET DANVERS, Mass., Apr 18, 2011 (BUSINESS WIRE) --Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that new data from the PROTECT II study will be presented by William O'Neill, M.D., executive dean for clinical affairs at the University of Miami Miller School of Medicine, and principa... 
Printer Friendly Version
04/03/11Abiomed Announces Schedule of Events at American College of Cardiology 2011 Scientific Conference
DANVERS, Mass., Apr 03, 2011 (BUSINESS WIRE) --Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the schedule of events at American College of Cardiology (ACC) 2011 Scientific Conference in New Orleans. Schedule of Abiomed Events at ACC 2011 Impella presentations at ACC 2011 will take place during the following dates and times: Sunday, April 3 12:30 p.m. CT Room 257 Ernest N. Morial Convention ... 
Printer Friendly Version
03/24/11Abiomed to Host PROTECT II Investor Meeting at ACC 2011
- Presentation Will Be Webcast Live and Available on Abiomed Website DANVERS, Mass., Mar 24, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, will host a PROTECT II investor and analyst meeting and webcast from ACC 2011 on Monday, April 4, from 8:00 - 9:00 a.m. ET. The presentation will include the PROTECT II data, which will be presented by William O'Neill, M.D., University of Miam... 
Printer Friendly Version
02/22/11PROTECT II Study Results Accepted for Presentation at 2011 ACC Show During Late Breaking Sessions
- Presentation Updated to Include Data From Approximately All 430 Patients Enrolled in Study DANVERS, Mass., Feb 22, 2011 (BUSINESS WIRE) --Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that the PROTECT II results have been accepted to be presented by William O'Neill, M.D., University of Miami, during the late-breaking clinical trials session at the American College of Cardiology (ACC... 
Printer Friendly Version
02/04/11Abiomed to Ring NASDAQ Closing Bell; Signifying Start of Heart Month and Celebrating a Successful Quarter
Female Heart Recovery Patients Will Join Abiomed CEO for Ceremony NASDAQ Ceremony Follows Abiomed Third Quarter Earnings Announcement DANVERS, Mass., Feb 04, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will ring the Closing Bell for The NASDAQ Stock Market today at 4 ... 
Printer Friendly Version
02/03/11Abiomed Increases Revenues by 19% to $27.2 Million and Achieves Non-GAAP Profitability While Generating $5 Million in Cash for Third Quarter of Fiscal 2011
- Record U.S. Utilization of 752 Patients, Up 77% Over Prior Year DANVERS, Mass., Feb 03, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2011 revenue of $27.2 million, up 19% compared to the same period of fiscal 2010. Worldwide Impella revenue totaled $21.1 million, up 33% compared to revenue of $15.9 million during the same period of the prior year. ... 
Printer Friendly Version
01/26/11Abiomed Third Quarter Fiscal 2011 Earnings and Conference Call Notification
DANVERS, Mass., Jan 26, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD) announced today that on Thursday, February 3, 2011, the Company will release financial results for the third quarter of fiscal 2011. The Company will host a conference call to discuss the results on Thursday, February 3, 2011, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L. Bowen, Vice President and Chief Financial Officer,... 
Printer Friendly Version
01/06/11Abiomed to Present at JP Morgan 29th Annual Healthcare Conference in San Francisco
DANVERS, Mass., Jan 06, 2011 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD) today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the 29th Annual JP Morgan Healthcare Conference on Thursday, January 13, 2010 at 10:30 a.m. PT/ 1:30 p.m. ET. The conference will be held at the Westin St. Francis from January 10 - 13, in San Francisco, California. A live audio webcast of the presentation will be availabl... 
Printer Friendly Version